Top Clinical Trials companies in the world by Revenue

This ranking features the top 1,494 Clinical Trials companies in the world ranked by Revenue, totaling a Revenue of USD 2.22 T, for June 28, 2025.

#	Name	Market Capitalization Share Price Year-To-Date (YTD) return Price to Earnings Ratio (P/E) EBIT EBITDA Net Income Free Cash Flow Dividend Yield Free Cash Flow Yield Total Assets Total Liabilities Cash and Short-Term Investments	Stock Price	Change	Price (30 days)	52W low/high	Sector

Items per page

1 2 3 4 … 30

Frequently Asked Questions

Which Clinical Trials company in the world has the highest Revenue ?

The Clinical Trials company in the world with the highest Revenue is Cencora, Inc. (NYSE: COR) at USD 310.23 B.
Which Clinical Trials company in the world has the lowest Revenue ?

The Clinical Trials company in the world with the lowest Revenue is Adocia SA (Paris Stock Exchange: ADOC.PA) at None.

What are the top 10 Clinical Trials companies in the world by Revenue ?

The top 10 Clinical Trials companies in the world by Revenue are Cencora, Inc., Sinopharm Group Co. Ltd., Roche Holding AG, Merck & Co., Inc., Pfizer Limited, Pfizer Inc., AbbVie Inc., AstraZeneca PLC, Novartis AG and Eli Lilly and Company.
What are the bottom 10 Clinical Trials companies in the world by Revenue ?

The bottom 10 Clinical Trials companies in the world by Revenue are Adocia SA, Affluent Medical SA, ABVC BioPharma, Inc., Adagio Medical Holdings, Inc., Adverum Biotechnologies, Inc., Addex Therapeutics Ltd, Shanghai Bio-heart Biological Technology Co., Ltd., 2cureX AB (publ), ABIVAX SA and Akari Therapeutics, Plc.